國泰君安(02611.HK)批准附屬參與投資賽領境內二期基金
國泰君安(02611.HK)公布,批准全資附屬國泰君安證裕作為有限合夥人,與控股股東旗下賽領揚帆,連同上汽投資、上海興嘉以及贛江投資,訂立賽領基金有限合夥協議,參與賽領境內二期基金,以間接投資設立賽領開曼二期基金。
公司指,目前並未簽署賽領基金有限合夥協議。
基金有限合夥人意向出資總額為19億元人民幣(下同),其中國泰君安證裕出資10億元,上汽投資、上海興嘉以及贛江投資分別出資5億元、3億元及1億元。賽領揚帆作為普通合夥人,亦將認繳賽領境內二期基金出資額不低於人民幣100萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.